49 -1 (33) 2021 — Maksudova M.M. — MODERN APPROACHES TO ESTIMATING THE OVARIAL RESERVE IN THE OLDER REPRODUCTIVE AGE

MODERN APPROACHES TO ESTIMATING THE OVARIAL RESERVE IN THE OLDER REPRODUCTIVE AGE

Maksudova M.M.-Tashkent Medical Academy

Resume

The emergence and development of assisted reproductive technologies has become a new stage in the development of infertility treatment, in addition, they have provided a number of new opportunities in the study of pathogenetic, morphological, embryological, cytogenetic aspects of reproductive medicine. The question remains open, what is the cornerstone of age-related infertility – the quality of oocytes or impairment in implantation? This review discusses current approaches to assessing the ovarian reserve in older reproductive age, the remaining problems in this area, as well as promising areas of research designed to provide solutions to emerging challenges.

Key words: assisted reproductive technologies, in vitro fertilization, ovarian reserve, gametes

First page

260

Last page

264

For citation: Maksudova M.M. Modern approaches to estimating the ovarial reserve in the older reproductive age//New Day in Medicine 1(33)2021 260-264 https://cutt.ly/Ix1A3Ai

LIST OF REFERENCES

  1. Adashi E.Y., Barri P.N., Berkowitz R., Braude P., Bryan E., Carr J., Cohen J., Collins J., Devroey P., Frydman R., Gardner D., Germond M., Gerris J., Gianaroli L., Hamberger L., Howles C., Jones H. Jr., Lunenfeld B., Pope A., Reynolds M., Rosenwaks Z., Shieve L.A., Serour G.I., Shenfield F., Templeton A., van Steirteghem A., Veeck L., Ulla-Britt W. Infertility therapy-associated multiple pregnancies (births): anongoing epidemic. Reprod Biomed Online 2003; 7: 515–42.
  2. Bancsi L.F., Broekmans F.J., Eijkemans M.J., de Jong F.H., Habbema J.D., TeVelde E.R. Predictors of poor ovarian response in in vitro fertilization: a prospective study comparing basal markers of ovarianreserve. FertilSteril 2002; 77: 328–36.
  3. Creus M., Penarrubia J., Fabregues F., Vidal E., Carmona F., Casamitjana R., Vanrell J.A., Balasch J. Day 3 serum inhibin B andFSH and age as predictors of assisted reproduction treatment outcome. Hum Reprod 2000; 15: 2341–6.
  4. Dor J., Lerner-Geva L., Rabinovici J., Chetrit A., Levran D., Lunenfeld B., Mashiach S., Modan B. Cancer incidence in a cohort of infertilewomen who underwent in vitro fertilization. FertilSteril 2002; 77:324–7.
  5. Fried G., Remaeus K., Harlin J., Krog E., Csemiczky G., Aanesen A., Tally M. Inhibin B predicts oocyte number and the ratio IGF-I/IGFBP-1 may indicate oocyte quality during ovarian hyperstimulation for in vitro fertilization. J Assist Reprod Genet 2003;20: 167–76.
  6. Garcia J.E., Jones G.S., Acosta A.A., Wright G.J. HMG/HCG follicularmaturation of oocyte aspiration: phase II, 1981. FertilSteril 1983;39: 174–9.
  7. Gleicher N., Pratt D., Dudkiewicz A. What do we really knowabout autoantibody abnormalities and reproductive failure: acritical review. Autoimmunity 1993; 16: 115–40.11 J. REPRODUKTIONSMED. ENDOKRINOL. 1/2005
  8. Hirtenlehner-Ferber K., Krampl E., Strohmer H., Husslein P. Multiplepregnancy. TherUmsch 2002; 59: 683–8.
  9. Huber J. EndokrineGynäkologie. Wilhelm Maudrich, Wien,1998.
49-260-264-БухМИ

file

download